Do Weight-loss Peptides Need To Be Taken Long-term?

Feb 05, 2026

Leave a message

Whether weight-loss peptides need to be taken long-term depends on individual circumstances, the type of medication, and the weight loss goal. Not everyone needs lifelong medication, but long-term maintenance therapy is a reasonable and necessary choice for some individuals.

From a medical perspective, weight-loss peptide drugs (such as GLP-1 receptor agonists) are essentially chronic weight management tools, similar to the long-term medication logic for hypertension or diabetes. Whether to continue use depends on the following factors:

 

The type of medication determines the duration of use.

GLP-1 receptor agonists (such as smegglutide and dulaglutide): Clinical studies show that at least 12 weeks of use is required to show stable weight loss effects, while the ideal treatment course is usually 6 months to 1 year. If the weight loss goal is achieved and weight is stable, the dosage can be gradually reduced and discontinued under the guidance of a doctor.

Dual-target new drugs (such as telpotetide and mastartide): Due to their higher weight loss efficiency, some patients can reach their goal in a shorter time, but maintenance medication is still recommended to consolidate the effect and prevent rebound.

High Risk of Weight Rebound After Discontinuation: Most people experience increased appetite and slower metabolism after discontinuing the weight-loss peptides, leading to a higher probability of weight rebound. This is not due to drug dependence, but rather because existing unhealthy lifestyle habits remain unchanged. Therefore, the essence of long-term medication is to buy time for lifestyle reshaping.

 

Safety of Long-Term Use:

Studies have shown that semaglutide can be safely used for at least 4 years (208 weeks), consistently resulting in weight loss and cardiovascular benefits.

However, potential side effects should be noted: Gastrointestinal discomfort (nausea, constipation, etc.) occurs in approximately 40% of cases. A small number of individuals may experience pancreatitis, gallstones, or thyroid C-cell tumors, thus requiring regular medical monitoring.

The Key is "Transition, Not Dependence": The ideal path is: medication-assisted weight loss → lifestyle reconstruction → gradual discontinuation for maintenance. If healthy eating and exercise habits can be established during medication use, the success rate of maintenance after discontinuation is significantly improved.